Skip to search.
 STI Down 0.18%

Biogen Inc. (BIIB)

-NasdaqGS
419.44 Down 9.21(2.15%) 18 Apr 04:00 SGT
|After Hours : 419.00 Down 0.44 (0.10%) 18 Apr 07:53 SGT
Add to Portfolio
Prev Close:428.65
Open:424.00
Bid:418.08 x 200
Ask:419.44 x 1200
1y Target Est:480.67
Beta:0.58
Next Earnings Date:24-Apr-15BIIB Earnings announcement
Day's Range:416.84 - 426.99
52wk Range:275.39 - 480.18
Volume:1,837,610
Avg Vol (3m):1,854,670
Market Cap:98.41B
P/E (ttm):33.91
EPS (ttm):12.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBDown 2.15%98.41B
PFEDown 0.43%214.76B

Key Statistics

Forward P/E (1 yr):21.02
P/S (ttm):10.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :16.97
Quarterly EPS Est (Mar-15) :3.91
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.43

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback